Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201211110 Principal Investigator: Adkins, Douglas
Title: A Phase I Trial of Pazopanib Suspension plus Cetuximab in Patients with Incurable Head and Neck Squamous Cell Carcinoma
Phase: I Disease Site: Lip, Oral Cavity and Pharynx
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this research study is to find the best dose of the study drug (pazopanib) in combination with cetuximab, as well as to see what the side effects of this treatment regimen are in patients with head and neck cancer.
 
More Information:
ClinicalTrials.Gov Link
Internal Protocol Documents (requires Siteman administrative database password)